Laura Melado

ORCID: 0000-0001-5450-4130 · 5 papers in corpus
other 2026
Case Reports in Obstetrics and Gynecology ·doi:10.1155/crog/4150637

OBJECTIVE: The objective of this study is to evaluate the effectiveness of prolonged GnRH agonist (GnRH-a) suppression combined with letrozole and intensive luteal phase support in a patient with severe adenomyosis undergoing frozen-thawed …

case-report 2026
Journal of medical case reports ·doi:10.1186/s13256-026-05907-1

BACKGROUND: Adenomyosis negatively impacts fertility treatment outcomes by lowering clinical pregnancy rates, reducing live birth rates, and increasing miscarriage rates following in vitro fertilization. Hormonal suppression therapy has eme…

review 2024
Best practice & research. Clinical obstetrics & gynaecology ·doi:10.1016/j.bpobgyn.2024.102456

As a chronic inflammatory disease, endometriosis generates fibrosis and anatomic distortion, which add extra-challenges to assisted reproductive technology cycles and requires a personalized approach. Patients with endometriomas have signif…

book-chapter 2020
·doi:10.1201/9781351241694-8

Luteal phase support is becoming a highly personalized treatment based on each stimulation protocol and patient characteristics. After the application of human chorionic gonadotrophin (hCG) for final oocyte maturation, the vaginal route for…

article 2007
·doi:10.1016/s0304-5013(07)73236-3

Resumen Presentamos el caso de una paciente con endometriosis infiltrativa profunda, previamente intervenida de endometriosis ovarica, y su manejo posterior. La clinica de la paciente fue el indicador principal de la progresion de la enferm…